SCHEMBL8160226

SCHEMBL8160226

CSc1nc(Nc2ccc3c(c2)CCC3)cc(=O)[nH]1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.48
▸ MAPT P10636 3/20 0.48
▸ USP2 O75604 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ BLM P54132 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ TDP1 Q9NUW8 1/20 0.48
▸ RECQL P46063 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ POLA1 P09884 1/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.42
▸ TSHR P16473 2/20 0.42
▸ LMNA P02545 3/20 0.41
▸ HTT P42858 1/20 0.41
▸ RAPGEF4 Q8WZA2 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ NPC1 O15118 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10157871 0.80 MKNK1 (0.45) POLB
SCHEMBL10156550 0.74 POLB (0.48) POLBMAPTBLMTDP1RECQL
SCHEMBL10156777 0.73 POLB (0.42) POLBSMN1; SMN2MEN1KMT2A
SCHEMBL10156704 0.73 ROCK1 (0.45) POLBMAPTUSP2SMN1; SMN2TSHR
SCHEMBL10157157 0.72 ROCK1 (0.50) POLBMAPTBLMTDP1SMN1; SMN2
SCHEMBL17422233 0.70 POLB (0.50) POLBMAPTRAB9ASMN1; SMN2TSHR
SCHEMBL10157834 0.70 POLB (0.44) POLBMAPTTHRBBLMHSD17B10
SCHEMBL10156964 0.70 TNNI3K (0.55) POLB
SCHEMBL7962176 0.70 UNG (0.57) POLBMAPTHSD17B10POLA1SMN1; SMN2
SCHEMBL10157033 0.69 POLB (0.48) POLBUSP2SMN1; SMN2TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772439-B1 Novel antibiotic compounds and antibiotic compositions comprising said compounds for inhibiting gram positive bacteria and mycoplasma cells. UNIV MASSACHUSETTS MEDICAL (US) 2000-10-04 — — EP disclosed
EP-0772439-A4 NOVEL ANTIBIOTIC COMPOUNDS AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS UNIV MASSACHUSETTS MEDICAL (US) 1998-01-07 — — EP disclosed
EP-0772439-A1 NOVEL ANTIBIOTIC COMPOUNDS AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) 1997-05-14 — — EP disclosed
US-5516905-A ENZYME INHIBITORS OF DNA POLYMERASE FOR BACTERICIDES UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) 1996-05-14 — — US disclosed
WO-1996006614-A1 NOVEL ANTIBIOTIC COMPOUNDS AND METHODS TO TREAT GRAM-POSITIVE BACTERIAL AND MYCOPLASMAL INFECTIONS UNIVERSITY OF MASSACHUSETTS MEDICAL CENTER (US) 1996-03-07 — — WO disclosed
Send feedback